One of the main reasons for limited pediatric-specific research is the ethical and logistical challenges. Conducting clinical trials in children involves stringent ethical considerations to ensure their safety and well-being. Additionally, obtaining parental consent and child assent can be complex. The smaller market size for pediatric medications also results in less pharmaceutical investment.
